However, Mehta et al. recently found that CAV1 deficiency in glomerular mesangial cells can inhibit miR299a-5p, which may posttranscriptionally regulate the expression of follostatin, thereby exerting an anti-renal fibrosis effect (Mehta et al., 2021). This evidence concerns the gene CAV1 and renal fibrosis.